This compound is a pharmaceutical intermediate primarily used in peptide synthesis. It features a complex molecular structure with multiple aromatic rings and ether linkages, characteristic of protected amino acid derivatives.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 431041-83-7
2-[4-[(2,4-Dimethoxyphenyl)[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl]phenoxy]acetic acid
Fmoc-protected amino acid linker
Fmoc-AEEA-AEEA
peptide synthesis intermediate
(4R)-5-(tert-butoxy)-4-{[(tert-butoxy)carbonyl]amino}-5-oxopentanoic acid
peptide synthesis intermediate
L-Asparagine, N2-[(1,1-dimethylethoxy)carbonyl]-
peptide synthesis intermediate
(5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid
peptide synthesis intermediate
2-cyanoethyl 3-aminocrotonate
Pharmaceutical intermediate
2-[4-(trifluoromethoxy)phenyl]acetic acid
pharmaceutical intermediate
6-chloro-3-methylpyrimidine-2,4(1H,3H)-dione
Pharmaceutical intermediate for alogliptin and trelagliptin
9H-fluoren-9-ylmethyl N-[[4-[2-[bis(4-methylphenyl)methylamino]-2-oxoethoxy]phenyl]-(2,4-dimethoxyphenyl)methyl]carbamate
JDDWRLPTKIOUOF-UHFFFAOYSA-N
CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)NC(=O)COC3=CC=C(C=C3)C(C4=C(C=C(C=C4)OC)OC)NC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57